These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 28375556)
21. Mitochondria transfer via tunneling nanotubes is an important mechanism by which CD133+ scattered tubular cells eliminate hypoxic tubular cell injury. Zou X; Hou Y; Xu J; Zhong L; Zhou J; Zhang G; Sun J Biochem Biophys Res Commun; 2020 Jan; 522(1):205-212. PubMed ID: 31759629 [TBL] [Abstract][Full Text] [Related]
22. Protective effect and localization by optical imaging of human renal CD133+ progenitor cells in an acute kidney injury model. Grange C; Moggio A; Tapparo M; Porta S; Camussi G; Bussolati B Physiol Rep; 2014; 2(5):e12009. PubMed ID: 24793983 [TBL] [Abstract][Full Text] [Related]
23. CD133+ renal progenitor cells contribute to tumor angiogenesis. Bruno S; Bussolati B; Grange C; Collino F; Graziano ME; Ferrando U; Camussi G Am J Pathol; 2006 Dec; 169(6):2223-35. PubMed ID: 17148683 [TBL] [Abstract][Full Text] [Related]
24. Controlled Delivery of Stem Cell-Derived Trophic Factors Accelerates Kidney Repair After Renal Ischemia-Reperfusion Injury in Rats. Yim HE; Kim DS; Chung HC; Shing B; Moon KH; George SK; Kim MW; Atala Z; Kim JH; Ko IK; Yoo JJ Stem Cells Transl Med; 2019 Sep; 8(9):959-970. PubMed ID: 31144785 [TBL] [Abstract][Full Text] [Related]
25. Expression of stem cell marker CD133 in fetal and adult human kidneys and pauci-immune crescentic glomerulonephritis. Kim K; Park BH; Ihm H; Kim KM; Jeong J; Chang JW; Cho YM Histol Histopathol; 2011 Feb; 26(2):223-32. PubMed ID: 21154236 [TBL] [Abstract][Full Text] [Related]
26. Regenerative medicine in kidney disease: where we stand and where to go. Borges FT; Schor N Pediatr Nephrol; 2018 Sep; 33(9):1457-1465. PubMed ID: 28735502 [TBL] [Abstract][Full Text] [Related]
27. Paracrine proangiopoietic effects of human umbilical cord blood-derived purified CD133+ cells--implications for stem cell therapies in regenerative medicine. Ratajczak J; Kucia M; Mierzejewska K; Marlicz W; Pietrzkowski Z; Wojakowski W; Greco NJ; Tendera M; Ratajczak MZ Stem Cells Dev; 2013 Feb; 22(3):422-30. PubMed ID: 23003001 [TBL] [Abstract][Full Text] [Related]
28. GMP-conformant on-site manufacturing of a CD133 Skorska A; Müller P; Gaebel R; Große J; Lemcke H; Lux CA; Bastian M; Hausburg F; Zarniko N; Bubritzki S; Ruch U; Tiedemann G; David R; Steinhoff G Stem Cell Res Ther; 2017 Feb; 8(1):33. PubMed ID: 28187777 [TBL] [Abstract][Full Text] [Related]
29. Improved differentiation of human enriched CD133+CD24 Ehsani E; Shekarchian S; Baharvand H; Aghdami N; Moghadasali R Differentiation; 2019; 109():1-8. PubMed ID: 31323479 [TBL] [Abstract][Full Text] [Related]
30. Bmi-1 plays a critical role in the protection from acute tubular necrosis by mobilizing renal stem/progenitor cells. Lv X; Yu Z; Xie C; Dai X; Li Q; Miao D; Jin J Biochem Biophys Res Commun; 2017 Jan; 482(4):742-749. PubMed ID: 27871857 [TBL] [Abstract][Full Text] [Related]
31. Human umbilical cord-derived mesenchymal stromal cells protect against premature renal senescence resulting from oxidative stress in rats with acute kidney injury. Rodrigues CE; Capcha JM; de Bragança AC; Sanches TR; Gouveia PQ; de Oliveira PA; Malheiros DM; Volpini RA; Santinho MA; Santana BA; Calado RD; Noronha IL; Andrade L Stem Cell Res Ther; 2017 Jan; 8(1):19. PubMed ID: 28129785 [TBL] [Abstract][Full Text] [Related]
32. Isolation of renal progenitor cells from adult human kidney. Bussolati B; Bruno S; Grange C; Buttiglieri S; Deregibus MC; Cantino D; Camussi G Am J Pathol; 2005 Feb; 166(2):545-55. PubMed ID: 15681837 [TBL] [Abstract][Full Text] [Related]
33. New Insights into the Renal Progenitor Cells and Kidney Diseases by Studying CD133. Bussolati B; Camussi G Adv Exp Med Biol; 2013; 777():113-23. PubMed ID: 23161079 [TBL] [Abstract][Full Text] [Related]
34. Hypoxia modulates the undifferentiated phenotype of human renal inner medullary CD133+ progenitors through Oct4/miR-145 balance. Bussolati B; Moggio A; Collino F; Aghemo G; D'Armento G; Grange C; Camussi G Am J Physiol Renal Physiol; 2012 Jan; 302(1):F116-28. PubMed ID: 21900452 [TBL] [Abstract][Full Text] [Related]
36. Regenerative medicine for the kidney: renotropic factors, renal stem/progenitor cells, and stem cell therapy. Maeshima A; Nakasatomi M; Nojima Y Biomed Res Int; 2014; 2014():595493. PubMed ID: 24895592 [TBL] [Abstract][Full Text] [Related]
38. Toward the identification of a "renopoietic system"? Romagnani P Stem Cells; 2009 Sep; 27(9):2247-53. PubMed ID: 19739254 [TBL] [Abstract][Full Text] [Related]
39. Amniotic Fluid Derived Stem Cells with a Renal Progenitor Phenotype Inhibit Interstitial Fibrosis in Renal Ischemia and Reperfusion Injury in Rats. Monteiro Carvalho Mori da Cunha MG; Zia S; Oliveira Arcolino F; Carlon MS; Beckmann DV; Pippi NL; Luhers Graça D; Levtchenko E; Deprest J; Toelen J PLoS One; 2015; 10(8):e0136145. PubMed ID: 26295710 [TBL] [Abstract][Full Text] [Related]
40. Acceleration of skeletal muscle regeneration in a rat skeletal muscle injury model by local injection of human peripheral blood-derived CD133-positive cells. Shi M; Ishikawa M; Kamei N; Nakasa T; Adachi N; Deie M; Asahara T; Ochi M Stem Cells; 2009 Apr; 27(4):949-60. PubMed ID: 19353523 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]